Delivery Order SPE2DE24D0013-SPE2D625F1QBG

The U.S. Defense Department's Medical Supply Chain agency awarded a $12,040 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 21, 2025, with completion expected by August 28, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, does not utilize a set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award supports the federal government's diagnostic testing capabilities through Cepheid's molecular diagnostic solutions, which are integral to detecting COVID-19, influenza, and respiratory syncytial virus (RSV) across defense and civilian healthcare systems.

This delivery order represents a continuation of Cepheid's substantial presence in the federal diagnostics marketplace, where the company operates under two significant Veterans Affairs IDV contracts valued at approximately $32.8 million and $2.5 million, respectively. Cepheid specializes in GeneXpert molecular diagnostic systems, reagents, and test kits that address critical defense and healthcare agency needs for infectious disease detection and laboratory testing services. The delivery order leverages Cepheid's established federal contract relationships and competitive positioning as a prime contractor for molecular diagnostic equipment and supplies across multiple federal agencies, including the Defense Logistics Agency and the Defense Health Agency.